The Anti-Fibrotic Effect of Bone Morphogenic Protein-7(BMP-7) on Liver Fibrosis
Authors:
Open Access
- 1 January 2013
- journal article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 10 (4) , 441-450
Abstract
Background/Aims : Transforming growth factor-β1 (TGF-β1) plays an important role in the pathogenesis of liver fibrosis and cirrhosis. Recombinant human bone morphogenic protein-7 (rhBMP-7) alleviates renal fibrosis and improves kidney function. However, the beneficial effect of BMP-7 on hepatic fibrosis and cirrhosis remains unknown. The purpose of this study was to investigate the prophylactic and therapeutic effects of rhBMP-7 on liver fibrosis and the underlying mechanisms. Methods : Liver fibrosis in the rat model was induced by peritoneal injection of porcine-serum (0.5ml/kg body weight) twice a week over 8 weeks. The effect of rhBMP-7 on hepatic fibrosis was monitored in rhBMP-7 pre-treated and non-treated rats. Pathologic changes were determined by immunohistolocial staining. TGF-β1 expression was investigated by immunohistolocial staining, western blotting, and real-time PCR. Collagen secretion was measured by enzyme-linked immunosorbent assay. Results : Liver fibrosis was significantly reduced by rhBMP-7. The secretion of collagen type-I and -III was decreased by rhBMP-7 in hepatic stellate cells (HSCs) but not in hepatocytes. The anti-fibrotic effect of rhBMP-7 on liver fibrosis was resulted by blocking the nuclear accumulation of Smad2/3 or by inhibiting TGF-β1 expression in HSCs or hepatocytes. Conclusions : The anti-fibrogenic mechanism of rhBMP-7 in the rat liver fibrosis was depended on the reduction of TGF-β1 overexpression and the inhibition of TGF-β1 triggered intracellular signalling in hepatic cells.Keywords
This publication has 48 references indexed in Scilit:
- Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine‐induced hepatic fibrosis in miceLiver International, 2009
- TGF-β1 Gene Silencing for Treating Liver FibrosisMolecular Pharmaceutics, 2009
- Decoding the quantitative nature of TGF-β/Smad signalingTrends in Cell Biology, 2008
- Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in ratsGut, 2007
- Common and unique mechanisms regulate fibrosis in various fibroproliferative diseasesJournal of Clinical Investigation, 2007
- PPARγ agonists prevent TGFβ1/Smad3-signaling in human hepatic stellate cellsBiochemical and Biophysical Research Communications, 2006
- PPM1A Functions as a Smad Phosphatase to Terminate TGFβ SignalingCell, 2006
- Cell Type-Specific Intervention of Transforming Growth Factor β/Smad Signaling Suppresses Collagen Gene Expression and Hepatic Fibrosis in MiceGastroenterology, 2005
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Myofibroblasts and mechano-regulation of connective tissue remodellingNature Reviews Molecular Cell Biology, 2002